The current research investigated whether berberine could be intracellular uptake and accessible to chromatin, inhibit proliferation, and influence DNA methylation states of CAR and its target gene CYP2B6 and CYP3A4 pathway in human hepatoma HepG2 cells. The gene discussed is NR1I3; the disease is hepatocellular carcinoma.